… -resistant prostate cancer will not respond to docetaxel-based therapy and all patients will
ultimately develop resistance… directions in the treatment of docetaxel-resistant prostate cancer. …

… inhibit docetaxel resistance in prostate cancer. There has been significant interest among
nanotechnologists to generate safe and effective drug (docetaxel) nanoformulations for cancer …

… of prostate cancer therapy. According to the present knowledge, different processes contribute
to the appearance of docetaxel resistance … involved in docetaxel resistance is described, …

… Docetaxel (DTX) chemotherapy offers excellent initial … -resistant prostate cancer (CRPC).
However, the clinical utility of DTX is compromised when primary and acquired resistance are …

… Overall, combination therapy with other anti-cancer agents [27], … prostate cancer. The current
review focuses on the capacity of prostate tumor cells in developing resistance to docetaxel …

… in classical multiple drug resistant pathways, expression of … three models of docetaxel-resistance
in prostate cancer cells … leading to treatment resistance. Understanding these pathways …

… -resistant prostate cancer (CRPC). However, most patients eventually develop resistance to
… associated with docetaxel resistance in two models of docetaxel-resistant CRPC cell lines …

… associated with cancer may be … with docetaxel-resistance in order to help determine the
complexity of this problem and to assess the relevance of secreted exosomes in prostate cancer. …

… of drug resistance. In this study, we established drug-resistant prostate cancer cell lines and
… with the development of drug resistance in prostate cancer. Actioning these mechanisms …

… resistance is documented and secondary hormone therapy is ineffective, standard treatment
of metastatic prostate cancer is docetaxel, … studies have evaluated docetaxel in combination …